Evidence map›Paper›PMID 30366982›Full record

ArticleThe Journal of biological chemistry2018

FAM210B is an erythropoietin target and regulates erythroid heme synthesis by controlling mitochondrial iron import and ferrochelatase activity.

Yvette Y Yien, Jiahai Shi, Caiyong Chen, Jesmine T M Cheung, Anthony S Grillo, Rishna Shrestha, Liangtao Li, Xuedi Zhang, Martin D Kafina, Paul D Kingsley and 14 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Nucleosome destabilization by polyamines.Archives of biochemistry and biophysics · 2022
    Article
  18. Regulation of Heme Synthesis by Mitochondrial Homeostasis Proteins.Frontiers in cell and developmental biology · 2022
    Review
  19. Review
  20. Using the Zebrafish as a Genetic Model to Study Erythropoiesis.International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 11 institutions in 1 country.

Yvette Y YienFrom the Department of Biological Sciences, University of Delaware, Newark, Delaware 19716, yyien@udel.edu.
Jiahai Shithe Whitehead Institute and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139.
Caiyong Chenthe Division of Hematology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115.
Jesmine T M Cheungthe Department of Chemistry and Biochemistry, UCLA, Los Angeles, California 90095.
Anthony S Grillothe Department of Chemistry and Biochemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801.
Rishna Shresthathe Department of Pathology, University of Utah School of Medicine, Salt Lake City, Utah 84112.
Liangtao Lithe Department of Pathology, University of Utah School of Medicine, Salt Lake City, Utah 84112.
Xuedi ZhangFrom the Department of Biological Sciences, University of Delaware, Newark, Delaware 19716.
Martin D Kafinathe Division of Hematology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115.
Paul D Kingsleythe Center for Pediatric Biomedical Research, Department of Pediatrics, University of Rochester Medical Center, Rochester, New York 14642.
Matthew J Kingthe Division of Hematology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115.
Julien Ablainthe Division of Hematology-Oncology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115.
Hojun Lithe Whitehead Institute and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139.
Leonard I Zonthe Division of Hematology-Oncology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115.
James Palisthe Center for Pediatric Biomedical Research, Department of Pediatrics, University of Rochester Medical Center, Rochester, New York 14642.
Martin D Burkethe Department of Chemistry and Biochemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801.
Daniel E Bauerthe Division of Hematology-Oncology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115.
Stuart H Orkinthe Division of Hematology-Oncology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115.
Carla M Koehlerthe Department of Chemistry and Biochemistry, UCLA, Los Angeles, California 90095.
John D Phillipsthe Division of Hematology and Hematologic Malignancy, University of Utah School of Medicine, Salt Lake City, Utah 84112.
Jerry Kaplanthe Department of Pathology, University of Utah School of Medicine, Salt Lake City, Utah 84112.
Diane M Wardthe Department of Pathology, University of Utah School of Medicine, Salt Lake City, Utah 84112.
Harvey F Lodishthe Whitehead Institute and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139.
Barry H Pawthe Division of Hematology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115.
University of Utah · USHarvard University · USDana-Farber Cancer Institute · USUniversity of California, Los Angeles · USUniversity of Illinois Urbana-Champaign · USUniversity of Rochester Medical Center · USWhitehead Institute for Biomedical Research · USBoston Children's Hospital · USBrigham and Women's Hospital · USMassachusetts Institute of Technology · USUniversity of Delaware · US

Funding

TRANSCRIPTION FACTOR GATA-1 IN TERMINAL ERYTHROID DEVELOPMENTP01HL032262 · NHLBI · CHILDREN'S HOSPITAL BOSTON · PI ORKIN, STUART H · 1985 to 2021
$38.9M
STRUCTURE-FUNCTION RELATIONSHIPS IN THE ALIMENTARY TRACTP30DK034854 · NIDDK · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WAYNE I LENCER · 1986 to 2026
$32.4M
Transcriptional mechanisms and melanomaP01CA163222 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI David Liu · 2013 to 2026
$25.3M
Porphyrias Consortium: SupplementU54DK083909 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI DESNICK, ROBERT J · 2009 to 2023
$18.5M
Proteomics CoreU54DK110858 · NIDDK · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Anna E Beaudin, JAMES Eric COX · 2016 to 2026
$8.6M
Biogenesis of the mitochondrial inner membrane diversity supplementR01GM061721 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KOEHLER, CARLA M · 2000 to 2025
$8.1M
Molecular Prosthetics and Lego ChemistryR35GM118185 · NIGMS · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI Martin D Burke · 2016 to 2026
$6.6M
A Community Zebrafish Resource for Modeling GWAS BiologyR24OD017870 · OD · BRIGHAM AND WOMEN'S HOSPITAL · PI GOESSLING, WOLFRAM, MACRAE, CALUM A. · 2014 to 2021
$6.3M
Project-002U54DK110805 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI ORKIN, STUART H, ZON, LEONARD IRA · 2016 to 2020
$5.9M
RNA trafficking in mitochondriaR01GM073981 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Carla M Koehler, MICHAEL A TEITELL · 2006 to 2026
$5.1M
FACTORS REGULATING THE CELLULAR UPTAKE OF IRONR37DK030534 · NIDDK · UNIVERSITY OF UTAH · PI KAPLAN, JERRY · 2000 to 2009
$3.3M
PORPHYRIN BIOSYNTHESIS IN NORMAL AND DISEASE STATESR01DK020503 · NIDDK · UNIVERSITY OF UTAH · PI PARKER, CHARLES J, PHILLIPS, JOHN DEARBORN · 1986 to 2012
$3.3M
NCI NIH HHS P01 CA163222NHLBI NIH HHS P01 HL032262NHLBI NIH HHS R01 HL116364NIDDK NIH HHS F32 DK098866NIDDK NIH HHS K01 DK106156NIDDK NIH HHS K08 DK093705NIDDK NIH HHS P30 DK034854NIDDK NIH HHS R01 DK020503NIDDK NIH HHS R01 DK030534NIDDK NIH HHS R01 DK070838NIDDK NIH HHS R01 DK071116NIDDK NIH HHS R03 DK118307NIDDK NIH HHS R37 DK030534NIDDK NIH HHS U54 DK083909NIDDK NIH HHS U54 DK110805NIDDK NIH HHS U54 DK110858NIGMS NIH HHS R01 GM061721NIGMS NIH HHS R01 GM073981NIGMS NIH HHS R35 GM118185NIH HHS R24 OD017870
6 · The paper itself

Abstract

Erythropoietin (EPO) signaling is critical to many processes essential to terminal erythropoiesis. Despite the centrality of iron metabolism to erythropoiesis, the mechanisms by which EPO regulates iron status are not well-understood. To this end, here we profiled gene expression in EPO-treated 32D pro-B cells and developing fetal liver erythroid cells to identify additional iron regulatory genes. We determined that FAM210B, a mitochondrial inner-membrane protein, is essential for hemoglobinization, proliferation, and enucleation during terminal erythroid maturation.

Indexed as

AnimalsErythroid CellsErythropoiesisErythropoietinFerrochelataseHEK293 CellsHemeHumansIronMembrane ProteinsMiceMitochondriaMitochondrial MembranesMitochondrial ProteinsProtein TransportErythropoietinFAM210B protein, humanFerrochelataseHemeIronMembrane ProteinsMitochondrial Proteinscell metabolismerythrocyteerythropoiesishemeiron metabolismred blood cell

Identifiers

PMID30366982
PMCPMC6314115
OpenAlexW2898145317

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.